| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $92.4M | +0.1% | +4.0% |
| Cost of Revenue | $51.1M | +0.3% | +7.5% |
| Gross Profit | $41.3M | -0.1% | -0.1% |
| R&D Expense | $4.8M | -7.1% | +37.6% |
| SG&A Expense | $18.2M | +7.6% | -5.7% |
| Operating Income | -$7.1M | -16.1% | +8.7% |
| Pre-tax Income | -$5.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $106.5M | +2.7% | +0.7% |
| Accounts Receivable | $40.4M | +4.6% | +17.9% |
| Inventory | $25.1M | +3.1% | +7.5% |
| Current Assets | $203.7M | +0.3% | +5.8% |
| Total Assets | $307.0M | -1.6% | +0.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.3M | — | — |
| Capital Expenditures | $1.5M | — | — |
| Investing Cash Flow | -$24.7M | — | — |
| Financing Cash Flow | $24.4M | — | — |
| Free Cash Flow | -$11.8M | — | — |
| -26.4% |
| +10.3% |
| Income Tax | -$146K | +4.6% | -44.6% |
| Net Income | -$5.3M | -27.5% | +11.2% |
| EPS (Basic) | -$0.20 | -33.3% | +20.0% |
| EPS (Diluted) | -$0.20 | -33.3% | +20.0% |
| $64.9M |
| -3.2% |
| -10.3% |
| Total Liabilities | $109.8M | -2.4% | -9.1% |
| Stockholders' Equity | $197.2M | -1.2% | +6.3% |